
When Laura Crane was diagnosed with Stage 3 melanoma a decade ago, searching for the right clinical trial felt like “enrolling in a heavy university course” at the worst possible moment.
The Thunder Bay teacher, now 47, burrowed down Google rabbit holes about skin-cancer research, trying to understand her options. She turned to her aunt, a physician in New Mexico, for guidance, and asked other doctors, friends and acquaintances what they knew about getting spots in trials.
From The Globe and Mail via this RSS feed